By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Global News TodayGlobal News TodayGlobal News Today
  • World
  • Politics
  • Business
  • Technology
  • Science
  • Entertainment
  • Sports
  • Health
Reading: 2 of Wall Street’s Favorite Stocks to Research Further and 1 Facing Challenges – StockStory
Share
Notification Show More
Font ResizerAa
Global News TodayGlobal News Today
Font ResizerAa
  • World
  • Politics
  • Sports
  • Business
  • Science
  • Technology
  • Entertainment
  • Home
    • Home 1
    • Home 2
    • Home 3
    • Home 4
    • Home 5
  • Demos
  • Categories
    • Technology
    • Business
    • Sports
    • Entertainment
    • World
    • Politics
    • Science
    • Health
  • Bookmarks
  • More Foxiz
    • Sitemap
Have an existing account? Sign In
Follow US
  • Advertise
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Science

2 of Wall Street’s Favorite Stocks to Research Further and 1 Facing Challenges – StockStory

Editorial Staff
Last updated: March 25, 2026 7:57 am
Editorial Staff
1 week ago
Share
SHARE

March 25, 2026
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
At StockStory, we look beyond the headlines with our independent analysis to determine whether these bullish calls are justified. That said, here are two stocks where Wall Street’s positive outlook is supported by strong fundamentals and one where consensus estimates seem disconnected from reality.
Consensus Price Target: $15.67 (34.8% implied return)
Headquartered in Providence, Rhode Island, Bally’s Corporation (NYSE:BALY) is a diversified global casino-entertainment company that owns and manages casinos, resorts, and online gaming platforms.
Why Do We Steer Clear of BALY?
Bally’s stock price of $11.63 implies a valuation ratio of 10.2x forward EV-to-EBITDA. Check out our free in-depth research report to learn more about why BALY doesn’t pass our bar.
Consensus Price Target: $478.58 (32.3% implied return)
Founded by two brothers in Michigan, Domino’s (NYSE:DPZ) is a globally recognized pizza chain known for its creative marketing and fast delivery.
Why Are We Fans of DPZ?
At $361.65 per share, Domino’s trades at 18.5x forward P/E. Is now the right time to buy? See for yourself in our comprehensive research report, it’s free.
Consensus Price Target: $400.20 (30.9% implied return)
Processing over 829 million transactions daily and connecting billions of cards to 150 million merchant locations worldwide, Visa (NYSE:V) operates one of the world’s largest electronic payments networks, facilitating secure money movement across more than 200 countries through its VisaNet processing platform.
Why Is V a Good Business?
Visa is trading at $305.72 per share, or 23x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
©2026 StockStory
Data sources: actuals and consensus estimates from StockStory, S&P Global Market Intelligence, and Visible Alpha. Market data from Massive.
Provided for general information purposes only and does not constitute investment advice or a recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific individual. Information on our investment framework and performance methodology is available here.
Copyright 2026, S&P Global Market Intelligence (and its affiliates as applicable). All rights reserved.

source

Linking TDP-43-regulated paraspeckle condensation to neuroprotection – Nature
SUNY Optometry Faculty Showcase Research Excellence During Expo Event for NY State Leaders – VisionMonday.com
Jack earns dissertation fellowship with Bureau of Economic Research – Nebraska Today
Paradiem LLC Has $19.94 Million Position in Lam Research Corporation $LRCX – MarketBeat
From engineered fungal molecules to drug leads, chem-bio hybrid synthesis enables antiparasitic drug discovery – Phys.org
Share This Article
Facebook Email Print
Previous Article People Are Sharing The "Excruciating" Movie Scenes That Are So Intense, They're Honestly Traumatizing – Yahoo
Next Article Wall Street is convinced AI will kill SaaS. History and economics say something else – Fortune
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • World
  • Politics
  • Business
  • Technology
  • Science
  • Entertainment
  • Sports
  • Health
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
[mc4wp_form]
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?